产业链上下游拓展

Search documents
乐氏国际控股(01529.HK)拟90万元收购亳州乐老号医药100%股权
Ge Long Hui· 2025-07-08 13:45
Group 1 - The company announced the acquisition of 100% equity in Bozhou Le Laohao Pharmaceutical Co., Ltd. for a total consideration of RMB 900,000, which was determined after fair negotiation between the parties [1] - The board anticipates that this acquisition will not have any significant adverse impact on the company's financial condition or operations in the short term [1] - The target company holds a Drug Business License and is primarily engaged in the wholesale and distribution of pharmaceuticals, sales of medical instruments, and wholesale of medical protective supplies, playing a crucial role in public health [1] Group 2 - The company plans to enhance management efficiency and integrate resources based on the existing business of the target company, aiming to become a comprehensive supply chain service provider [2] - The company intends to expand its business beyond basic distribution to provide value-added services such as financial, data, and management solutions for the industry chain [2] - The company aims to leverage digital technology to reduce operational costs and utilize artificial intelligence to improve decision-making accuracy, transforming its logistics capabilities into data, service, and financial strengths [2]